NADPH oxidases: Key modulators in aging and age-related cardiovascular diseases?

Clinical Science

Volumn 130, Issue 5, 2016, Pages 317-335

  Sahoo, Sanghamitra ^a   Meijles, Daniel N ^a   Pagano, Patrick J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cardiovascular diseases; Reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase; Reduced nicotinamide adenine dinucleotide phosphate oxidase therapeutics (Nox therapeutics)

Indexed keywords

CELL NUCLEUS DNA; KLOTHO PROTEIN; PROTEIN P21; PROTEIN P53; PROTEIN P66; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SOMATOMEDIN; CARDIOVASCULAR AGENT;

AGING; ARTICLE; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CARDIOVASCULAR DISEASES; ENZYMOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; OXIDATION REDUCTION REACTION; PHYSIOLOGY; PROCEDURES;

AGING; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; HUMANS; MOLECULAR TARGETED THERAPY; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84958092751     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150087     Document Type: Article

References (271)

1. Lakatta, E.G. (2002) Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail. Rev. 7, 29-49
2. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S. et al. (2013) Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127, e6-e245
3. Heidenreich, P.A., Trogdon, J.G., Khavjou, O.A., Butler, J., Dracup, K., Ezekowitz, M.D., Finkelstein, E.A., Hong, Y., Johnston, S.C., Khera, A. et al. (2011) Forecasting the future of cardiovascular disease in the united states: a policy statement from the American Heart Association. Circulation 123, 933-944
4. Jin, K. (2010) Modern biological theories of aging. Aging Dis. 1, 72-74
5. Viña, J., Borras, C. and Miquel, J. (2007) Theories of ageing. IUBMB Life 59, 249-254
6. Harman, D. (1956) Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298-300
7. Lopez-Otin, C., Blasco, M.A., Partridge, L., Serrano, M. and Kroemer, G. (2013) The hallmarks of aging. Cell 153, 1194-1217
8. van Deursen, J.M. (2014) The role of senescent cells in ageing. Nature 509, 439-446
9. Munoz-Espin, D. and Serrano, M. (2014) Cellular senescence: from physiology to pathology. Nat. Rev. Mol. Cell Biol. 15, 482-496
10. von Zglinicki, T. (2002) Oxidative stress shortens telomeres. Trends Biochem. Sci. 27, 339-344
11. Houben, J.M., Moonen, H.J., van Schooten, F.J. and Hageman, G.J. (2008) Telomere length assessment: biomarker of chronic oxidative stress? Free Radic. Biol. Med. 44, 235-246
12. Lithgow, G.J. and Kirkwood, T.B. (1996) Mechanisms and evolution of aging. Science 273, 80
13. Orr, W.C. and Sohal, RS. (1994) Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263, 1128-1130
14. Taub, J., Lau, J.F., Ma, C., Hahn, J.H., Hoque, R., Rothblatt, J. and Chalfie, M. (1999) A cytosolic catalase is needed to extend adult lifespan in C. elegans daf-c and Clk-1 mutants. Nature 399, 162-166
15. Hamilton, M.L., Van Remmen, H., Drake, J.A., Yang, H., Guo, Z.M., Kewitt, K., Walter, C.A. and Richardson, A. (2001) Does oxidative damage to DNA increase with age? Proc. Natl. Acad. Sci. U.S.A. 98, 10469-10474
16. Elchuri, S., Oberley, T.D., Qi, W., Eisenstein, R.S., Jackson Roberts, L., Van Remmen, H., Epstein, C.J. and Huang, T.T. (2005) Cu/ZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24, 367-380
17. Li, Y., Huang, T.T., Carlson, E.J., Melov, S., Ursell, P.C., Olson, J.L., Noble, L.J., Yoshimura, M.P., Berger, C., Chan, P.H. et al. (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11,376-381
18. Melov, S., Coskun, P., Patel, M., Tuinstra, R., Cottrell, B., Jun, A.S., Zastawny, T.H., Dizdaroglu, M., Goodman, S.I., Huang, T.T. et al. (1999) Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 96, 846-851
19. Nonn, L., Williams, R.R., Erickson, R.P. and Powis, G. (2003) The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23, 916-922
20. Sentman, M.L., Granstrom, M., Jakobson, H., Reaume, A., Basu, S. and Marklund, S.L. (2006) Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutase. J. Biol. Chem. 281, 6904-6909
21. Zhang, Y., Ikeno, Y., Qi, W., Chaudhuri, A., Li, Y., Bokov, A., Thorpe, S.R., Baynes, J.W., Epstein, C., Richardson, A. and Van Remmen, H. (2009) Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity. J. Gerontol. A Biol. Sci. Med. Sci. 64, 1212-1220
22. Perez, V.I., Van Remmen, H., Bokov, A., Epstein, C.J., Vijg, J. and Richardson, A. (2009) The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging Cell 8, 73-75
23. de Haan, J.B., Bladier, C., Lotfi-Miri, M., Taylor, J., Hutchinson, P., Crack, P.J., Hertzog, P. and Kola, I. (2004) Fibroblasts derived from gpx1 knockout mice display senescent-like features and are susceptible to H2O2-mediated cell death. Free Radic. Biol. Med. 36, 53-64
24. Van Remmen, H., Williams, M.D., Guo, Z., Estlack, L., Yang, H., Carlson, E.J., Epstein, C.J., Huang, T.T. and Richardson, A. (2001) Knockout mice heterozygous for sod2 show alterations in cardiac mitochondrial function and apoptosis. Am. J. Physiol. Heart Circ. Physiol. 281, H1422-H1432
25. Sundaresan, M., Yu, Z.X., Ferrans, V.J., Irani, K. and Finkel, T. (1995) Requirement for generation of h2o2 for platelet-derived growth factor signal transduction. Science +270, 296-299
26. Finkel, T. (2003) Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15, 247-254
27. Hensley, K., Robinson, K.A., Gabbita, S.P., Salsman, S. and Floyd, R.A. (2000) Reactive oxygen species, cell signaling, and cell injury. Free Radic. Biol. Med. 28, 1456-1462
28. Wang, X., McCullough, K.D., Franke, T.F. and Holbrook, N.J. (2000) Epidermal growth factor receptor-dependent akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 275, 14624-14631
29. Cifuentes, M.E., Rey, F.E., Carretero, O.A. and Pagano, P.J. (2000) Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin ii-infused mice. Am. J. Physiol. Heart Circ. Physiol. 279, H2234-H2240
30. Pagano, P.J., Clark, J.K., Cifuentes-Pagano, M.E., Clark, S.M., Callis, G.M. and Quinn, M.T. (1997) Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin ii. Proc. Natl. Acad. Sci. U.S.A. 94, 14483-14488
31. Giordano, F.J. (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 115, 500-508
32. Lambeth, J.D. (2004) Nox enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181-189
33. Nishida, M., Maruyama, Y., Tanaka, R., Kontani, K., Nagao, T. and Kurose, H. (2000) G alpha(i) and g alpha(o) are target proteins of reactive oxygen species. Nature 408, 492-495
34. Johnson, T.M., Yu, Z.X., Ferrans, V.J., Lowenstein, R.A. and Finkel, T. (1996) Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 93, 11848-11852
35. Griendling, K.K. and FitzGerald, G.A. (2003) Oxidative stress and cardiovascular injury: part i: basic mechanisms and in vivo monitoring of ROS. Circulation 108, 1912-1916
36. Korantzopoulos, P., Kolettis, T.M., Galaris, D. and Goudevenos, J.A. (2007) The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int. J. Cardiol. 115, 135-143
37. Youn, J.Y., Zhang, J., Zhang, Y., Chen, H., Liu, D., Ping, P., Weiss, J.N. and Cai, H. (2013) Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J. Mol. Cell. Cardiol. 62, 72-79
38. Kim, Y.M., Guzik, T.J., Zhang, Y.H., Zhang, M.H., Kattach, H., Ratnatunga, C., Pillai, R., Channon, K.M. and Casadei, B. (2005) A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ. Res. 97, 629-636
39. Kim, Y.M., Kattach, H., Ratnatunga, C., Pillai, R., Channon, K.M. and Casadei, B. (2008) Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J. Am. Coll. Cardiol. 51, 68-74
40. Zalba, G., Beaumont, J., San Jose, G., Fortuno, A., Fortuno, M.A. and Diez, J. (2000) Vascular oxidant stress: Molecular mechanisms and pathophysiological implications. J. Physiol. Biochem. 56, 57-64
41. Griendling, K.K. and Alexander, R.W. (1997) Oxidative stress and cardiovascular disease. Circulation 96, 3264-3265
42. Landmesser, U. and Harrison, D.G. (2001) Oxidant stress as a marker for cardiovascular events: Ox marks the spot. Circulation 104, 2638-2640
43. Csanyi, G., Taylor, W.R. and Pagano, P.J. (2009) Nox and inflammation in the vascular adventitia. Free Radic. Biol. Med. 47, 1254-1266
44. Zhang, M., Brewer, A.C., Schroder, K., Santos, C.X., Grieve, D.J., Wang, M., Anilkumar, N., Yu, B., Dong, X., Walker, S.J. et al. (2010) NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc. Natl. Acad. Sci. U.S.A. +107, 18121-18126
45. Frazziano, G., Al Ghouleh, I., Baust, J., Shiva, S., Champion, H.C. and Pagano, P.J. (2014) Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension: indications for a seminal role for mitochondrial Nox4. Am. J. Physiol. Heart Circ. Physiol. 306, H197-H205
46. Al Ghouleh, I., Frazziano, G., Rodriguez, A.I., Csanyi, G., Maniar, S., St Croix, C.M., Kelley, E.E., Egana, L.A., Song, G.J., Bisello, A. et al. (2013) Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy. Cardiovasc. Res. 97, 134-142
47. Frazziano, G., Champion, H.C. and Pagano, P.J. (2012) NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone. Am. J. Physiol. Heart Circ. Physiol. 302, H2166-H2177
48. Al Ghouleh, I., Khoo, N.K., Knaus, U.G., Griendling, K.K., Touyz, R.M., Thannickal, V.J., Barchowsky, A., Nauseef, W.M., Kelley, E.E., Bauer, P.M. et al. (2011) Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic. Biol. Med. 51, 1271-1288
49. Haurani, M.J. and Pagano, P.J. (2007) Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease? Cardiovasc. Res. 75, 679-689
50. Liu, J., Yang, F., Yang, X.P., Jankowski, M. and Pagano, P.J. (2003) NAD(P)H oxidase mediates angiotensin ii-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler. Thromb. Vasc. Biol. 23, 776-782
51. Touyz, R.M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M.T., Pagano, P.J. and Schiffrin, E.L. (2002) Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin ii. Circ. Res. 90, 1205-1213
52. Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P.P., Lanfrancone, L. and Pelicci, P.G. (1999) The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309-313
53. Napoli, C., Martin-Padura, I., de Nigris, F., Giorgio, M., Mansueto, G., Somma, P., Condorelli, M., Sica, G., De Rosa, G. and Pelicci, P. (2003) Deletion of the p66shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc. Natl. Acad. Sci. U.S.A. 100, 2112-2116
54. Nemoto, S. and Finkel, T. (2002) Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295, 2450-2452
55. Trinei, M., Giorgio, M., Cicalese, A., Barozzi, S., Ventura, A., Migliaccio, E., Milia, E., Padura, I.M., Raker, V.A., Maccarana, M. et al. (2002) A p53-p66shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 21, 3872-3878
56. Lin, S.J., Defossez, P.A. and Guarente, L. (2000) Requirement of NAD and Sir2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289, 2126-2128
57. Rogina, B. and Helfand, S.L. (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U.S.A. 101, 15998-16003
58. Herranz, D., Munoz-Martin, M., Canamero, M., Mulero, F., Martinez-Pastor, B., Fernandez-Capetillo, O. and Serrano, M. (2010) Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat. Commun. 1, 3
59. Satoh, A., Brace, C.S., Rensing, N., Cliften, P., Wozniak, D.F., Herzog, E.D., Yamada, K.A. and Imai, S. (2013) Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 18, 416-430
60. Kuro-o, M, Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E. et al. (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45-51
61. Kurosu, H., Yamamoto, M., Clark, J.D., Pastor, J.V., Nandi, A., Gurnani, P., McGuinness, O.P., Chikuda, H., Yamaguchi, M., Kawaguchi, H. et al. (2005) Suppression of aging in mice by the hormone Klotho. Science 309, 1829-1833
62. Yamamoto, M., Clark, J.D., Pastor, J.V., Gurnani, P., Nandi, A., Kurosu, H., Miyoshi, M., Ogawa, Y., Castrillon, D.H., Rosenblatt, K.P. and Kuro-o, M. (2005) Regulation of oxidative stress by the anti-aging hormone klotho. J. Biol. Chem. 280, 38029-38034
63. Greer, E.L., Dowlatshahi, D., Banko, M.R., Villen, J., Hoang, K., Blanchard, D., Gygi, S.P. and Brunet, A. (2007) An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr. Biol. 17, 1646-1656
64. Tullet, J.M., Hertweck, M., An, J.H., Baker, J., Hwang, J.Y., Liu, S., Oliveira, R.P., Baumeister, R. and Blackwell, T.K. (2008) Direct inhibition of the longevity-promoting factor skn-1 by insulin-like signaling in C. elegans. Cell 132, 1025-1038
65. Wong, A., Boutis, P. and Hekimi, S. (1995) Mutations in the clk-1 gene of Caenorhabditis elegans affect developmental and behavioral timing. Genetics 139, 1247-1259
66. Lakowski, B. and Hekimi, S. (1996) Determination of life-span in Caenorhabditis elegans by four clock genes. Science 272, 1010-1013
67. Kenyon, C., Chang, J., Gensch, E., Rudner, A. and Tabtiang, R. (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366, 461-464
68. Kapahi, P., Zid, B.M., Harper, T., Koslover, D., Sapin, V. and Benzer, S. (2004) Regulation of lifespan in drosophila by modulation of genes in the tor signaling pathway. Curr. Biol. 14, 885-890
69. Kaeberlein, M., Powers, III, R.W., Steffen, K.K., Westman, E.A., Hu, D., Dang, N., Kerr, E.O., Kirkland, K.T., Fields, S. and Kennedy, B.K. (2005) Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science +310, 1193-1196
70. Griendling, K.K., Sorescu, D. and Ushio-Fukai, M. (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501
71. Guzik, T.J., West, N.E., Black, E., McDonald, D., Ratnatunga, C., Pillai, R. and Channon, K.M. (2000) Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ. Res. 86, E85-E90
72. Azumi, H., Inoue, N., Ohashi, Y., Terashima, M., Mori, T., Fujita, H., Awano, K., Kobayashi, K., Maeda, K., Hata, K. et al. (2002) Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: Important role of NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 22, 1838-1844
73. Martinet, W., Knaapen, M.W., De Meyer, G.R., Herman, A.G. and Kockx, M.M. (2002) Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106, 927-932
74. Bedard, K. and Krause, K.H. (2007) The Nox family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245-313
75. Touyz, R.M. (2004) Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44, 248-252
76. Cai, H. and Harrison, D.G. (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844
77. Lassegue, B., San Martin, A. and Griendling, K.K. (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 110, 1364-1390
78. Sorescu, D., Weiss, D., Lassegue, B., Clempus, R.E., Szocs, K., Sorescu, G.P., Valppu, L., Quinn, M.T., Lambeth, J.D. et al. (2002) Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 105, 1429-1435
79. Barry-Lane, P.A., Patterson, C., van der Merwe, M., Hu, Z., Holland, S.M., Yeh, E.T. and Runge, M.S. (2001) P47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J. Clin. Invest. 108, 1513-1522
80. Sheehan, A.L., Carrell, S., Johnson, B., Stanic, B., Banfi, B. and Miller, Jr, F. J. (2011) Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis 216, 321-326
81. Guzik, T.J., Chen, W., Gongora, M.C., Guzik, B., Lob, H.E., Mangalat, D., Hoch, N., Dikalov, S., Rudzinski, P., Kapelak, B. et al. (2008) Calcium-dependent nox5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J. Am. Coll. Cardiol. +52, 1803-1809
82. Ebrahimian, T., Li, M.W., Lemarie, C.A., Simeone, S.M., Pagano, P.J., Gaestel, M., Paradis, P., Wassmann, S. and Schiffrin, E.L. (2011) Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin ii-induced inflammation and hypertension: regulation of oxidative stress. Hypertension 57, 245-254
83. Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., Takai, S., Yamanishi, K., Miyazaki, M., Matsubara, H. and Yabe-Nishimura, C. (2005) Nox1 is involved in angiotensin ii-mediated hypertension: a study in Nox1-deficient mice. Circulation 112, 2677-2685
84. Liu, J.Q., Zelko, I.N., Erbynn, E.M., Sham, J.S. and Folz, R.J. (2006) Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L2-L10
85. Mittal, M., Roth, M., Konig, P., Hofmann, S., Dony, E., Goyal, P., Selbitz, A.C., Schermuly, R.T., Ghofrani, H.A., Kwapiszewska, G. et al. (2007) Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit Nox4 in the pulmonary vasculature. Circ. Res. 101, 258-267
86. Dudley, Jr, S.C., Hoch, N.E., McCann, L.A., Honeycutt, C., Diamandopoulos, L., Fukai, T., Harrison, D.G., Dikalov, S.I. and Langberg, J. (2005) Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation +112, 1266-1273
87. Kleikers, P.W., Wingler, K., Hermans, J.J., Diebold, I., Altenhofer, S., Radermacher, K.A., Janssen, B., Gorlach, A. and Schmidt, H.H. (2012) NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury. J. Mol. Med. 90, 1391-1406
88. Drummond, G.R. and Sobey, C.G. (2014) Endothelial NADPH oxidases: which Nox to target in vascular disease? Trends Endocrinol. Metab. 25, 452-463
89. von Lohneysen, K., Noack, D., Jesaitis, A.J., Dinauer, M.C. and Knaus, U.G. (2008) Mutational analysis reveals distinct features of the Nox4-p22 Phox complex. J. Biol. Chem. 283, 35273-35282
90. Cross, A.R. and Segal, A.W. (2004) The NADPH oxidase of professional phagocytes-prototype of the Nox electron transport chain systems. Biochim. Biophys. Acta +1657, 1-22
91. Pick, E. (2014) Role of the rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task. Small GTPases +5, e27952
92. Meijles, D.N., Fan, L.M., Howlin, B.J. and Li, J.M. (2014) Molecular insights of p47phox phosphorylation dynamics in the regulation of NADPH oxidase activation and superoxide production. J. Biol. Chem. 289, 22759-22770
93. Turgeon, J., Haddad, P., Dussault, S., Groleau, J., Maingrette, F., Perez, G. and Rivard, A. (2012) Protection against vascular aging in Nox2-deficient mice: Impact on endothelial progenitor cells and reparative neovascularization. Atherosclerosis 223, 122-129
94. Helmcke, I., Heumuller, S., Tikkanen, R., Schroder, K. and Brandes, R.P. (2009) Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxid. Redox Signal. 11, 1279-1287
95. Lyle, A.N., Deshpande, N.N., Taniyama, Y., Seidel-Rogol, B., Pounkova, L., Du, P., Papaharalambus, C., Lassegue, B. and Griendling, K.K. (2009) Poldip2, a novel regulator of nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ. Res. 105, 249-259
96. Touyz, R.M. and Montezano, A.C. (2012) Vascular nox4: a multifarious NADPH oxidase. Circ. Res. 110, 1159-1161
97. Nisimoto, Y., Diebold, B.A., Constentino-Gomes, D. and Lambeth, J.D. (2014) Nox4: a hydrogen peroxide-generating oxygen sensor. Biochemistry +53, 5111-5120
98. Bedard, K., Jaquet, V. and Krause, K.H. (2012) Nox5: from basic biology to signaling and disease. Free Radic. Biol. Med. 52, 725-734
99. Baniulis, D., Nakano, Y., Nauseef, W.M., Banfi, B., Cheng, G., Lambeth, D.J., Burritt, J.B., Taylor, R.M. and Jesaitis, AJ. (2005) Evaluation of two anti-gp91phox antibodies as immunoprobes for Nox family proteins: Mab 54.1 recognizes recombinant full-length Nox2, Nox3 and the C-terminal domains of Nox1-4 and cross-reacts with Grp 58. Biochim. Biophys. Acta 1752, 186-196
100. Haurani, M.J., Cifuentes, M.E., Shepard, A.D. and Pagano, P.J. (2008) Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin ii-induced adventitial myofibroblast migration. Hypertension 52, 143-149
101. Guzik, T.J., Sadowski, J., Kapelak, B., Jopek, A., Rudzinski, P., Pillai, R., Korbut, R. and Channon, K.M. (2004) Systemic regulation of vascular NAD(P)H oxidase activity and Nox isoform expression in human arteries and veins. Arterioscler. Thromb. Vasc. Biol. 24, 1614-1620
102. Zalba, G., Beaumont, F.J., San Jose, G., Fortuno, A., Fortuno, M.A., Etayo, J.C. and Diez, J. (2000) Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension +35, 1055-1061
103. Irani, K. (2000) Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87, 179-183
104. Ardanaz, N., Yang, X.P., Cifuentes, M.E., Haurani, M.J., Jackson, K.W., Liao, T.D., Carretero, O.A. and Pagano, PJ. (2010) Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiotensin ii hypertension. Hypertension 55, 116-123
105. Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B.A., Griendling, K.K. and Harrison, D.G. (1996) Angiotensin ii-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97, 1916-1923
106. Oskarsson, H.J. and Heistad, D.D. (1997) Oxidative stress produced by angiotensin too. Implications for hypertension and vascular injury. Circulation 95, 557-559
107. Cifuentes-Pagano, E., Meijles, D.N. and Pagano, P.J. (2014) The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls. Antioxid. Redox Signal. +20, 2741-2754
108. Drummond, G.R., Selemidis, S., Griendling, K.K. and Sobey, CG. (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10, 453-471
109. Altenhofer, S., Kleikers, P.W., Radermacher, K.A., Scheurer, P., Rob Hermans, J.J., Schiffers, P., Ho, H., Wingler, K. and Schmidt, H.H. (2012) The Nox toolbox: validating the role of NADPH oxidases in physiology and disease. Cell. Mol. Life Sci. 69, 2327-2343
110. Kalyanaraman, B., Darley-Usmar, V., Davies, K.J., Dennery, P.A., Forman, H.J., Grisham, M.B., Mann, G.E., Moore, K., Roberts, II, L. J. and Ischiropoulos, H. (2012) Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic. Biol. Med. 52, 1-6
111. Pelicci, G., Lanfrancone, L., Grignani, F., McGlade, J., Cavallo, F., Forni, G., Nicoletti, I., Grignani, F., Pawson, T. and Pelicci, P.G. (1992) A novel transforming protein (Shc) with an Sh2 domain is implicated in mitogenic signal transduction. Cell 70, 93-104
112. Pinton, P., Rimessi, A., Marchi, S., Orsini, F., Migliaccio, E., Giorgio, M., Contursi, C., Minucci, S., Mantovani, F., Wieckowski, M.R. et al. (2007) Protein kinase c beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66shc. Science 315, 659-663
113. Le, S., Connors, T.J. and Maroney, A.C. (2001) C-jun n-terminal kinase specifically phosphorylates p66shca at serine 36 in response to ultraviolet irradiation. J. Biol. Chem. 276, 48332-48336
114. Giorgio, M., Migliaccio, E., Orsini, F., Paolucci, D., Moroni, M., Contursi, C., Pelliccia, G., Luzi, L., Minucci, S., Marcaccio, M. et al. (2005) Electron transfer between cytochrome c and p66shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122, 221-233
115. Orsini, F., Migliaccio, E., Moroni, M., Contursi, C., Raker, V.A., Piccini, D., Martin-Padura, I., Pelliccia, G., Trinei, M., Bono, M. et al. (2004) The life span determinant p66shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J. Biol. Chem. 279, 25689-25695
116. Cai, W., He, J.C., Zhu, L., Chen, X., Striker, G.E. and Vlassara, H. (2008) Age-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation. Am. J. Physiol. Cell Physiol. 294, C145-C152
117. Berniakovich, I., Trinei, M., Stendardo, M., Migliaccio, E., Minucci, S., Bernardi, P., Pelicci, P.G. and Giorgio, M. (2008) P66shc-generated oxidative signal promotes fat accumulation. J. Biol. Chem. 283, 34283-34293
118. Tomilov, A.A., Bicocca, V., Schoenfeld, R.A., Giorgio, M., Migliaccio, E., Ramsey, J.J., Hagopian, K., Pelicci, P.G. and Cortopassi, G.A. (2010) Decreased superoxide production in macrophages of long-lived p66shc knock-out mice. J. Biol. Chem. 285, 1153-1165
119. Vousden, K.H. and Lu, X. (2002) Live or let die: the cell's response to p53. Nat. Rev. Cancer 2, 594-604
120. Haupt, Y., Maya, R., Kazaz, A. and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299
121. Mouraret, N., Marcos, E., Abid, S., Gary-Bobo, G., Saker, M., Houssaini, A., Dubois-Rande, J.L., Boyer, L., Boczkowski, J., Derumeaux, G. et al. (2013) Activation of lung p53 by nutlin-3a prevents and reverses experimental pulmonary hypertension. Circulation 127, 1664-1676
122. Dornan, D., Wertz, I., Shimizu, H., Arnott, D., Frantz, G.D., Dowd, P., O'Rourke, K., Koeppen, H. and Dixit, V.M. (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429, 86-92
123. Leng, R.P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J.M., Lozano, G., Hakem, R. and Benchimol, S. (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112, 779-791
124. Lee, J.T. and Gu, W. (2010) The multiple levels of regulation by p53 ubiquitination. Cell Death Differ. 17, 86-92
125. Brooks, C.L. and Gu, W. (2011) P53 regulation by ubiquitin. FEBS Lett. 585, 2803-2809
126. Bode, A.M. and Dong, Z. (2004) Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4, 793-805
127. Brooks, C.L. and Gu, W. (2011) The impact of acetylation and deacetylation on the p53 pathway. Protein Cell 2, 456-462
128. Abida, W.M., Nikolaev, A., Zhao, W., Zhang, W. and Gu, W. (2007) Fbxo11 promotes the neddylation of p53 and inhibits its transcriptional activity. J. Biol. Chem. 282, 1797-1804
129. Santiago, A., Li, D., Zhao, L.Y., Godsey, A. and Liao, D. (2013) P53 sumoylation promotes its nuclear export by facilitating its release from the nuclear export receptor crm1. Mol. Biol. Cell 24, 2739-2752
130. Leonova, K.I., Brodsky, L., Lipchick, B., Pal, M., Novototskaya, L., Chenchik, A.A., Sen, G.C., Komarova, E.A. and Gudkov, A.V. (2013) P53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs. Proc. Natl. Acad. Sci. U.S.A. 110, E89-E98
131. Bragado, P., Armesilla, A., Silva, A. and Porras, A. (2007) Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis 12, 1733-1742
132. Persons, D.L., Yazlovitskaya, E.M. and Pelling, J.C. (2000) Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J. Biol. Chem. 275, 35778-35785
133. Xie, S., Wang, Q., Wu, H., Cogswell, J., Lu, L., Jhanwar-Uniyal, M. and Dai, W. (2001) Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3. J. Biol. Chem. 276, 36194-36199
134. Hainaut, P. and Mann, K. (2001) Zinc binding and redox control of p53 structure and function. Antioxid. Redox Signal. 3, 611-623
135. Rainwater, R., Parks, D., Anderson, M.E., Tegtmeyer, P. and Mann, K. (1995) Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol. 15, 3892-3903
136. Buzek, J., Latonen, L., Kurki, S., Peltonen, K. and Laiho, M. (2002) Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277. Nucleic Acids Res. 30, 2340-2348
137. Tyner, S.D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C. et al. (2002) P53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53
138. Maier, B., Gluba, W., Bernier, B., Turner, T., Mohammad, K., Guise, T., Sutherland, A., Thorner, M. and Scrable, H. (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18, 306-319
139. Vigneron, A. and Vousden, K.H. (2010) P53, ROS and senescence in the control of aging. Aging 2, 471-474
140. Xu, S., Chamseddine, A.H., Carrell, S. and Miller, Jr, F.J. (2014) Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques. Redox Biol. 2, 642-650
141. Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J.M., Vina, J., Blasco, M.A. and Serrano, M. (2007) Delayed ageing through damage protection by the Arf/p53 pathway. Nature 448, 375-379
142. Italiano, D., Lena, A.M., Melino, G. and Candi, E. (2012) Identification of Ncf2/p67phox as a novel p53 target gene. Cell Cycle 11, 4589-4596
143. Fridman, J.S. and Lowe, S.W. (2003) Control of apoptosis by p53. Oncogene 22, 9030-9040
144. Olovnikov, I.A., Kravchenko, J.E. and Chumakov, P.M. (2009) Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense. Semin. Cancer Biol. 19, 32-41
145. Zuckerman, V., Wolyniec, K., Sionov, R.V., Haupt, S. and Haupt, Y. (2009) Tumour suppression by p53: The importance of apoptosis and cellular senescence. J. Pathol. 219, 3-15
146. Demidenko, Z.N., Korotchkina, L.G., Gudkov, A.V. and Blagosklonny, M.V. (2010) Paradoxical suppression of cellular senescence by p53. Proc. Natl. Acad. Sci. U.S.A. 107, 9660-9664
147. He, G., Siddik, Z.H., Huang, Z., Wang, R., Koomen, J., Kobayashi, R., Khokhar, A.R. and Kuang, J. (2005) Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 24, 2929-2943
148. Li, J.M., Fan, L.M., George, V.T. and Brooks, G. (2007) Nox2 regulates endothelial cell cycle arrest and apoptosis via p21cip1 and p53. Free Radic. Biol. Med. 43, 976-986
149. Jun, J.I. and Lau, L.F. (2010) The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat. Cell Biol. 12, 676-685
150. Kodama, R., Kato, M., Furuta, S., Ueno, S., Zhang, Y., Matsuno, K., Yabe-Nishimura, C., Tanaka, E. and Kamata, T. (2013) ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence. Genes Cells 18, 32-41
151. Morgan, R.G., Ives, S.J., Walker, A.E., Cawthon, R.M., Andtbacka, R.H., Noyes, D., Lesniewski, L.A., Richardson, R.S. and Donato, A.J. (2014) Role of arterial telomere dysfunction in hypertension: Relative contributions of telomere shortening and telomere uncapping. J. Hypertens. 32, 1293-1299
152. Kunieda, T., Minamino, T., Nishi, J., Tateno, K., Oyama, T., Katsuno, T., Miyauchi, H., Orimo, M., Okada, S., Takamura, M. et al. (2006) Angiotensin ii induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway. Circulation 114, 953-960
153. Arunachalam, G., Samuel, S.M., Marei, I., Ding, H. and Triggle, C.R. (2014) Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. Br. J. Pharmacol. 171, 523-535
154. Tavana, O., Puebla-Osorio, N., Sang, M. and Zhu, C. (2010) Absence of p53-dependent apoptosis combined with nonhomologous end-joining deficiency leads to a severe diabetic phenotype in mice. Diabetes 59, 135-142
155. Warboys, C.M., de Luca, A., Amini, N., Luong, L., Duckles, H., Hsiao, S., White, A., Biswas, S., Khamis, R., Chong, C.K. et al. (2014) Disturbed flow promotes endothelial senescence via a p53-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 34, 985-995
156. Wu, G., Cai, J., Han, Y., Chen, J., Huang, Z.P., Chen, C., Cai, Y., Huang, H., Yang, Y., Liu, Y. et al. (2014) Lincrna-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation 130, 1452-1465
157. Abid, S., Houssaini, A., Mouraret, N., Marcos, E., Amsellem, V., Wan, F., Dubois-Rande, J.L., Derumeaux, G., Boczkowski, J., Motterlini, R. and Adnot, S. (2014) P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension. Arterioscler. Thromb. Vasc. Biol. 34, 304-312
158. Kuro-o, M. (2009) Klotho and aging. Biochim. Biophys. Acta 1790, 1049-1058
159. Wolf, I., Levanon-Cohen, S., Bose, S., Ligumsky, H., Sredni, B., Kanety, H., Kuro-o, M, Karlan, B., Kaufman, B., Koeffler, H.P. and Rubinek, T. (2008) Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27, 7094-7105
160. de Oliveira, R.M. (2006) Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Lett. 580, 5753-5758
161. Kokkinaki, M., Abu-Asab, M., Gunawardena, N., Ahern, G., Javidnia, M., Young, J. and Golestaneh, N. (2013) Klotho regulates retinal pigment epithelial functions and protects against oxidative stress. J. Neurosci. 33, 16346-16359
162. Zeldich, E., Chen, C.D., Colvin, T.A., Bove-Fenderson, E.A., Liang, J., Tucker Zhou, T.B., Harris, D.A. and Abraham, C.R. (2014) The neuroprotective effect of klotho is mediated via regulation of members of the redox system. J. Biol. Chem. 289, 24700-24715
163. Hu, M.C., Shi, M., Zhang, J., Quinones, H., Griffith, C., Kuro-o, M. and Moe, O.W. (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J. Am. Soc. Nephrol. 22, 124-136
164. Lim, K., Lu, T.S., Molostvov, G., Lee, C., Lam, F.T., Zehnder, D. and Hsiao, L.L. (2012) Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 125, 2243-2255
165. Saito, K., Ishizaka, N., Mitani, H., Ohno, M. and Nagai, R. (2003) Iron chelation and a free radical scavenger suppress angiotensin ii-induced downregulation of klotho, an anti-aging gene, in rat. FEBS Lett. 551, 58-62
166. Fukino, K., Suzuki, T., Saito, Y., Shindo, T., Amaki, T., Kurabayashi, M. and Nagai, R. (2002) Regulation of angiogenesis by the aging suppressor gene Klotho. Biochem. Biophys. Res. Commun. 293, 332-337
167. Nagai, R., Saito, Y., Ohyama, Y., Aizawa, H., Suga, T., Nakamura, T., Kurabayashi, M. and Kuroo, M. (2000) Endothelial dysfunction in the Klotho mouse and downregulation of Klotho gene expression in various animal models of vascular and metabolic diseases. Cell. Mol. Life Sci. 57, 738-746
168. Saito, Y., Nakamura, T., Ohyama, Y., Suzuki, T., Iida, A., Shiraki-Iida, T., Kuro-o, M, Nabeshima, Y., Kurabayashi, M. and Nagai, R. (2000) In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem. Biophys. Res. Commun. 276, 767-772
169. Saito, Y., Yamagishi, T., Nakamura, T., Ohyama, Y., Aizawa, H., Suga, T., Matsumura, Y., Masuda, H., Kurabayashi, M., Kuro-o, M. et al. (1998) Klotho protein protects against endothelial dysfunction. Biochem. Biophys. Res. Commun. 248, 324-329
170. Arking, D.E., Becker, D.M., Yanek, L.R., Fallin, D., Judge, D.P., Moy, T.F., Becker, L.C. and Dietz, H.C. (2003) Klotho allele status and the risk of early-onset occult coronary artery disease. Am. J. Hum. Genet. 72, 1154-1161
171. Arking, D.E., Atzmon, G., Arking, A., Barzilai, N. and Dietz, H.C. (2005) Association between a functional variant of the klotho gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ. Res. 96, 412-418
172. Kuro-o, M. (2008) Klotho as a regulator of oxidative stress and senescence. Biol. Chem. 389, 233-241
173. Ravikumar, P., Ye, J., Zhang, J., Pinch, S.N., Hu, M.C., Kuro-o, M, Hsia, C.C. and Moe, O.W. (2014) Alpha-klotho protects against oxidative damage in pulmonary epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 307, L566-L575
174. Kim, Y.C., Masutani, H., Yamaguchi, Y., Itoh, K., Yamamoto, M. and Yodoi, J. (2001) Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J. Biol. Chem. 276, 18399-18406
175. Wang, Y., Kuro-o, M. and Sun, Z. (2012) Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway. Aging Cell 11, 410-417
176. Delafontaine, P., Song, Y.H. and Li, Y. (2004) Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler. Thromb. Vasc. Biol. 24, 435-444
177. Du, J., Peng, T., Scheidegger, K.J. and Delafontaine, P. (1999) Angiotensin ii activation of insulin-like growth factor 1 receptor transcription is mediated by a tyrosine kinase-dependent redox-sensitive mechanism. Arterioscler. Thromb. Vasc. Biol. 19, 2119-2126
178. Delafontaine, P. and Ku, L. (1997) Reactive oxygen species stimulate insulin-like growth factor i synthesis in vascular smooth muscle cells. Cardiovasc. Res. 33, 216-222
179. Murphy, C.T., McCarroll, S.A., Bargmann, C.I., Fraser, A., Kamath, R.S., Ahringer, J., Li, H. and Kenyon, C. (2003) Genes that act downstream of daf-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277-283
180. Hsu, A.L., Murphy, C.T. and Kenyon, C. (2003) Regulation of aging and age-related disease by daf-16 and heat-shock factor. Science 300, 1142-1145
181. Suh, Y., Atzmon, G., Cho, M.O., Hwang, D., Liu, B., Leahy, D.J., Barzilai, N. and Cohen, P. (2008) Functionally significant insulin-like growth factor i receptor mutations in centenarians. Proc. Natl. Acad. Sci. U.S.A. 105, 3438-3442
182. Pawlikowska, L., Hu, D., Huntsman, S., Sung, A., Chu, C., Chen, J., Joyner, A.H., Schork, N.J., Hsueh, W.C., Reiner, A.P. et al. (2009) Association of common genetic variation in the insulin/igf1 signaling pathway with human longevity. Aging Cell 8, 460-472
183. Liu, J.P., Baker, J., Perkins, A.S., Robertson, E.J. and Efstratiadis, A. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor i (IGF-1) and type 1 IGF receptor (IGF1R). Cell 75, 59-72
184. Khan, A.S., Sane, D.C., Wannenburg, T. and Sonntag, W.E. (2002) Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc. Res. 54, 25-35
185. Kaplan, R.C., McGinn, A.P., Pollak, M.N., Kuller, L., Strickler, H.D., Rohan, T.E., Cappola, A.R., Xue, X. and Psaty, B.M. (2008) High insulin-like growth factor binding protein 1 level predicts incident congestive heart failure in the elderly. Am. Heart J. 155, 1006-1012
186. Rosen, T. and Bengtsson, B.A. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336, 285-288
187. Sukhanov, S., Higashi, Y., Shai, S.Y., Vaughn, C., Mohler, J., Li, Y., Song, Y.H., Titterington, J. and Delafontaine, P. (2007) IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27, 2684-2690
188. Li, Q., Li, B., Wang, X., Leri, A., Jana, K.P., Liu, Y., Kajstura, J., Baserga, R. and Anversa, P. (1997) Overexpression of insulinlike growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 100, 1991-1999
189. Kajstura, J., Fiordaliso, F., Andreoli, A.M., Li, B., Chimenti, S., Medow, M.S., Limana, F., Nadal-Ginard, B., Leri, A. and Anversa, P. (2001) Igf-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin ii-mediated oxidative stress. Diabetes 50, 1414-1424
190. Li, Q., Wu, S., Li, S.Y., Lopez, F.L., Du, M., Kajstura, J., Anversa, P. and Ren, J. (2007) Cardiac-specific overexpression of insulinlike growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. Am. J. Physiol. Heart Circ. Physiol. 292, H1398-H1403
191. Ren, J., Duan, J., Thomas, D.P., Yang, X., Sreejayan, N., Sowers, J.R., Leri, A., Kajstura, J., Gao, F. and Anversa, P. (2008) IGF-i alleviates diabetes-induced rhoA activation, eNOS uncoupling, and myocardial dysfunction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R793-R802
192. Csiszar, A., Labinskyy, N., Perez, V., Recchia, F.A., Podlutsky, A., Mukhopadhyay, P., Losonczy, G., Pacher, P., Austad, S.N., Bartke, A. and Ungvari, Z. (2008) Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am. J. Physiol. Heart Circ. Physiol. 295, H1882-H1894
193. Bailey-Downs, L.C., Mitschelen, M., Sosnowska, D., Toth, P., Pinto, J.T., Ballabh, P., Valcarcel-Ares, M.N., Farley, J., Koller, A., Henthorn, J.C. et al. (2012) Liver-specific knockdown of igf-1 decreases vascular oxidative stress resistance by impairing the nrf2-dependent antioxidant response: a novel model of vascular aging. J. Gerontol. A Biol. Sci. Med. Sci. 67, 313-329
194. Li, Q., Ceylan-Isik, A.F., Li, J. and Ren, J. (2008) Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction. Rejuvenation Res. 11, 725-733
195. Li, Q., Yang, X., Sreejayan, N. and Ren, J. (2007) Insulin-like growth factor i deficiency prolongs survival and antagonizes paraquat-induced cardiomyocyte dysfunction: role of oxidative stress. Rejuvenation Res. 10, 501-512
196. Hua, Y., Zhang, Y. and Ren, J. (2012) Igf-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a. J. Cell. Mol. Med. 16, 83-95
197. Lakatta, E.G. (1993) Cardiovascular regulatory mechanisms in advanced age. Physiol. Rev. 73, 413-467
198. Olivetti, G., Melissari, M., Capasso, J.M. and Anversa, P. (1991) Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ. Res. 68, 1560-1568
199. Wang, M., Zhang, J., Walker, S.J., Dworakowski, R., Lakatta, E.G. and Shah, A.M. (2010) Involvement of NADPH oxidase in age-associated cardiac remodeling. J. Mol. Cell. Cardiol. 48, 765-772
200. Ago, T., Matsushima, S., Kuroda, J., Zablocki, D., Kitazono, T. and Sadoshima, J. (2010) The NADPH oxidase Nox4 and aging in the heart. Aging 2, 1012-1016
201. Wang, M., Zhang, J., Jiang, L.Q., Spinetti, G., Pintus, G., Monticone, R., Kolodgie, F.D., Virmani, R. and Lakatta, E.G. (2007) Proinflammatory profile within the grossly normal aged human aortic wall. Hypertension 50, 219-227
202. Franklin, S.S., Gustin, 4th, W., Wong, N.D., Larson, M.G., Weber, M.A., Kannel, W.B. and Levy, D. (1997) Hemodynamic patterns of age-related changes in blood pressure. The Framingham heart study. Circulation 96, 308-315
203. O'Rourke, M.F. and Hashimoto, J. (2007) Mechanical factors in arterial aging: a clinical perspective. J. Am. Coll. Cardiol. 50, 1-13
204. Virmani, R., Avolio, A.P., Mergner, W.J., Robinowitz, M., Herderick, E.E., Cornhill, J.F., Guo, S.Y., Liu, T.H., Ou, D.Y. and O'Rourke, M. (1991) Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am. J. Pathol. 139, 1119-1129
205. Colavitti, R. and Finkel, T. (2005) Reactive oxygen species as mediators of cellular senescence. IUBMB Life 57, 277-281
206. Lassegue, B. and Griendling, K.K. (2010) NADPH oxidases: functions and pathologies in the vasculature. Arterioscler. Thromb. Vasc. Biol. 30, 653-661
207. Azumi, H., Inoue, N., Takeshita, S., Rikitake, Y., Kawashima, S., Hayashi, Y., Itoh, H. and Yokoyama, M. (1999) Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 100, 1494-1498
208. Vendrov, A.E., Hakim, Z.S., Madamanchi, N.R., Rojas, M., Madamanchi, C. and Runge, M.S. (2007) Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells. Arterioscler. Thromb. Vasc. Biol. 27, 2714-2721
209. Judkins, C.P., Diep, H., Broughton, B.R., Mast, A.E., Hooker, E.U., Miller, A.A., Selemidis, S., Dusting, G.J., Sobey, C.G. and Drummond, G.R. (2010) Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability and early atherosclerotic plaque formation in ApoE-/- mice. Am. J. Physiol. Heart Circ. Physiol. 298, H24-H32
210. Douglas, G., Bendall, J.K., Crabtree, M.J., Tatham, A.L., Carter, E.E., Hale, A.B. and Channon, K.M. (2012) Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE(-)/(-) mice. Cardiovasc. Res. 94, 20-29
211. Gray, S.P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A.C., de Haan, J.B., Koulis, C., El-Osta, A., Andrews, K.L. et al. (2013) NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation 127, 1888-1902
212. Montezano, A.C., Burger, D., Paravicini, T.M., Chignalia, A.Z., Yusuf, H., Almasri, M., He, Y., Callera, G.E., He, G., Krause, K.H. et al. (2010) Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin ii and endothelin-1 is mediated via calcium/calmodulin-dependent, Rac-1-independent pathways in human endothelial cells. Circ. Res. 106, 1363-1373
213. Ragnauth, C.D., Warren, D.T., Liu, Y., McNair, R., Tajsic, T., Figg, N., Shroff, R., Skepper, J. and Shanahan, C.M. (2010) Prelamin a acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 121, 2200-2210
214. Kavurma, M.M., Figg, N., Bennett, M.R., Mercer, J., Khachigian, L.M. and Littlewood, T.D. (2007) Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment. Biochem. J. 407, 79-87
215. Higashi, Y., Oshima, T., Ozono, R., Matsuura, H. and Kajiyama, G. (1997) Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension 30, 252-258 CrossRef
216. Hotta, H. and Uchida, S. (2010) Aging of the autonomic nervous system and possible improvements in autonomic activity using somatic afferent stimulation. Geriatr. Gerontol. Int. 10 (Suppl. 1), S127-S136
217. Ross, R. (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126
218. Higashi, Y., Sasaki, S., Nakagawa, K., Matsuura, H., Oshima, T. and Chayama, K. (2002) Endothelial function and oxidative stress in renovascular hypertension. N. Engl. J. Med. 346, 1954-1962
219. Ito, N., Ohishi, M., Yamamoto, K., Tatara, Y., Shiota, A., Hayashi, N., Komai, N., Yanagitani, Y., Rakugi, H. and Ogihara, T. (2007) Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats. Am. J. Hypertens. 20, 792-799
220. Dikalova, A., Clempus, R., Lassegue, B., Cheng, G., McCoy, J., Dikalov, S., San Martin, A., Lyle, A., Weber, D.S., Weiss, D. et al. (2005) Nox1 overexpression potentiates angiotensin ii-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 112, 2668-2676
221. Basset, O., Deffert, C., Foti, M., Bedard, K., Jaquet, V., Ogier-Denis, E. and Krause, K.H. (2009) NADPH oxidase 1 deficiency alters caveolin phosphorylation and angiotensin ii-receptor localization in vascular smooth muscle. Antioxid. Redox Signal. 11, 2371-2384
222. Wang, Y. and Sun, Z. (2009) Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 54, 810-817
223. Frost, A.E., Badesch, D.B., Barst, R.J., Benza, R.L., Elliott, C.G., Farber, H.W., Krichman, A., Liou, T.G., Raskob, G.E., Wason, P. et al. (2011) The changing picture of patients with pulmonary arterial hypertension in the united states: how reveal differs from historic and non-us contemporary registries. Chest 139, 128-137
224. Ling, Y., Johnson, M.K., Kiely, D.G., Condliffe, R., Elliot, C.A., Gibbs, J.S., Howard, L.S., Pepke-Zaba, J., Sheares, K.K., Corris, P.A. et al. (2012) Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am. J. Respir. Crit. Care Med. 186, 790-796
225. Hoeper, M.M., Huscher, D., Ghofrani, H.A., Delcroix, M., Distler, O., Schweiger, C., Grunig, E., Staehler, G., Rosenkranz, S., Halank, M. et al. (2013) Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the compera registry. Int. J. Cardiol. 168, 871-880
226. Hoeper, M.M., Bogaard, H.J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., Wilkins, M.R. and Badesch, DB. (2013) Definitions and diagnosis of pulmonary hypertension. J. Am. Coll. Cardiol. 62, D42-D50
227. Stenmark, K.R., Fagan, K.A. and Frid, M.G. (2006) Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ. Res. 99, 675-691
228. Li, S., Tabar, S.S., Malec, V., Eul, B.G., Klepetko, W., Weissmann, N., Grimminger, F., Seeger, W., Rose, F. and Hanze, J. (2008) Nox4 regulates ros levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Antioxid. Redox Signal. 10, 1687-1698
229. Nisbet, R.E., Graves, A.S., Kleinhenz, D.J., Rupnow, H.L., Reed, A.L., Fan, T.H., Mitchell, P.O., Sutliff, R.L. and Hart, C.M. (2009) The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice. Am. J. Respir. Cell Mol. Biol. 40, 601-609
230. Barman, S.A., Chen, F., Su, Y., Dimitropoulou, C., Wang, Y., Catravas, J.D., Han, W., Orfi, L., Szantai-Kis, C., Keri, G. et al. (2014) NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 34, 1704-1715
231. Wolf, P.A., Abbott, R.D. and Kannel, W.B. (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22, 983-988
232. Kalus, J.S., White, C.M., Caron, M.F., Coleman, C.I., Takata, H. and Kluger, J. (2004) Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. Ann. Thorac. Surg. 77, 1288-1292
233. Anter, E., Jessup, M. and Callans, D.J. (2009) Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation 119, 2516-2525
234. Pozzoli, M., Cioffi, G., Traversi, E., Pinna, G.D., Cobelli, F. and Tavazzi, L. (1998) Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J. Am. Coll. Cardiol. 32, 197-204
235. Schnabel, R.B., Sullivan, L.M., Levy, D., Pencina, M.J., Massaro, J.M., D'Agostino, Sr., R. B., Newton-Cheh, C., Yamamoto, J.F., Magnani, J.W., Tadros, T.M. et al. (2009) Development of a risk score for atrial fibrillation (Framingham heart study): a community-based cohort study. Lancet 373, 739-745
236. Elahi, M.M., Flatman, S. and Matata, B.M. (2008) Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon. Eur. J. Cardiovasc. Prev. Rehabil. 15, 735-741
237. Mihm, M.J., Yu, F., Carnes, C.A., Reiser, P.J., McCarthy, P.M., Van Wagoner, D.R. and Bauer, J.A. (2001) Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104, 174-180
238. Neuman, R.B., Bloom, H.L., Shukrullah, I., Darrow, L.A., Kleinbaum, D., Jones, D.P. and Dudley, Jr, S.C. (2007) Oxidative stress markers are associated with persistent atrial fibrillation. Clin. Chem. 53, 1652-1657
239. Burstein, B. and Nattel, S. (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J. Am. Coll. Cardiol. 51, 802-809
240. Zhang, J., Youn, J.Y., Kim, A.Y., Ramirez, R.J., Gao, L., Ngo, D., Chen, P., Scovotti, J., Mahajan, A. and Cai, H. (2012) Nox4-dependent hydrogen peroxide overproduction in human atrial fibrillation and hl-1 atrial cells: relationship to hypertension. Front. Physiol. 3, 140
241. Reilly, S.N., Jayaram, R., Nahar, K., Antoniades, C., Verheule, S., Channon, K.M., Alp, N.J., Schotten, U. and Casadei, B. (2011) Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 124, 1107-1117
242. Adam, O., Frost, G., Custodis, F., Sussman, M.A., Schafers, H.J., Bohm, M. and Laufs, U. (2007) Role of Rac1 GTPase activation in atrial fibrillation. J. Am. Coll. Cardiol. 50, 359-367
243. Chang, J.P., Chen, M.C., Liu, W.H., Yang, C.H., Chen, C.J., Chen, Y.L., Pan, K.L., Tsai, T.H. and Chang, H.W. (2011) Atrial myocardial nox2 containing NADPH oxidase activity contribution to oxidative stress in mitral regurgitation: potential mechanism for atrial remodeling. Cardiovasc. Pathol. 20, 99-106
244. Yeh, Y.H., Kuo, C.T., Chan, T.H., Chang, G.J., Qi, X.Y., Tsai, F., Nattel, S. and Chen, W.J. (2011) Transforming growth factor-beta and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes. Cardiovasc. Res. 91, 62-70
245. Adam, O., Lavall, D., Theobald, K., Hohl, M., Grube, M., Ameling, S., Sussman, M.A., Rosenkranz, S., Kroemer, H.K., Schafers, H.J. et al. (2010) Rac1-induced connective tissue growth factor regulates connexin 43 and n-cadherin expression in atrial fibrillation. J. Am. Coll. Cardiol. 55, 469-480
246. Cai, H., Griendling, K.K. and Harrison, D.G. (2003) The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24, 471-478
247. Streeter, J., Thiel, W., Brieger, K. and Miller, Jr, F. J. (2013) Opportunity Nox: the future of NADPH oxidases as therapeutic targets in cardiovascular disease. Cardiovasc. Ther. 31, 125-137
248. Fan, Y.F., Zhang, R., Jiang, X., Wen, L., Wu, D.C., Liu, D., Yuan, P., Wang, Y.L. and Jing, Z.C. (2013) The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension. Cardiovasc. Res. 99, 395-403
249. Muzaffar, S., Shukla, N., Srivastava, A., Angelini, G.D. and Jeremy, J.Y. (2005) Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells. Br. J. Pharmacol. 146, 109-117
250. Juraschek, S.P., Guallar, E., Appel, L.J. and Miller, III, E.R. (2012) Effects of vitamin c supplementation on blood pressure: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 95, 1079-1088
251. Sesso, H.D., Christen, W.G., Bubes, V., Smith, J.P., MacFadyen, J., Schvartz, M., Manson, J.E., Glynn, R.J., Buring, J.E. and Gaziano, J.M. (2012) Multivitamins in the prevention of cardiovascular disease in men: The physicians' health study ii randomized controlled trial. JAMA 308, 1751-1760
252. McCance, D.R., Holmes, V.A., Maresh, M.J., Patterson, C.C., Walker, J.D., Pearson, D.W. and Young, I.S. (2010) Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (dapit): a randomised placebo-controlled trial. Lancet. 376, 259-266
253. ten Freyhaus, H., Huntgeburth, M., Wingler, K., Schnitker, J., Baumer, A.T., Vantler, M., Bekhite, M.M., Wartenberg, M., Sauer, H. and Rosenkranz, S. (2006) Novel Nox inhibitor Vas2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc. Res. 71, 331-341
254. Wind, S., Beuerlein, K., Eucker, T., Muller, H., Scheurer, P., Armitage, M.E., Ho, H., Schmidt, H.H. and Wingler, K. (2010) Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br. J. Pharmacol. 161, 885-898
255. Allison, A.C., Cacabelos, R., Lombardi, V.R., Alvarez, X.A. and Vigo, C. (2001) Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1341-1357
256. Smith, S.M., Min, J., Ganesh, T., Diebold, B., Kawahara, T., Zhu, Y., McCoy, J., Sun, A., Snyder, J.P., Fu, H., Du, Y., Lewis, I. and Lambeth, J.D. (2012) Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits. Chem. Biol. 19, 752-763
257. Wang, Q., Zhou, H., Gao, H., Chen, S.H., Chu, C.H., Wilson, B. and Hong, J.S. (2012) Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidase. J. Neuroinflammation 9, 32
258. Cifuentes-Pagano, E., Saha, J., Csanyi, G., Ghouleh, I.A., Sahoo, S., Rodriguez, A., Wipf, P., Pagano, P.J. and Skoda, E.M. (2013) Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors. Medchemcomm 4, 1085-1092
259. Gianni, D., Taulet, N., Zhang, H., DerMardirossian, C., Kister, J., Martinez, L., Roush, W.R., Brown, S.J., Bokoch, G.M. and Rosen, H. (2010) A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells. ACS Chem. Biol. 5, 981-993
260. Laleu, B., Gaggini, F., Orchard, M., Fioraso-Cartier, L., Cagnon, L., Houngninou-Molango, S., Gradia, A., Duboux, G., Merlot, C., Heitz, F. et al. (2010) First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J. Med. Chem. 53, 7715-7730
261. Gaggini, F., Laleu, B., Orchard, M., Fioraso-Cartier, L., Cagnon, L., Houngninou-Molango, S., Gradia, A., Duboux, G., Merlot, C., Heitz, F. et al. (2011) Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual nox4/nox1 inhibitors. Bioorg. Med. Chem. 19, 6989-6999
262. Shin, Y.S., Song, S.J., Kang, S.U., Hwang, H.S., Choi, J.W., Lee, B.H., Jung, Y.S. and Kim, C.H. (2013) A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1h-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study. Neuroscience 232, 1-12
263. Kofler, P.A., Pircher, H., von Grafenstein, S., Diener, T., Holl, M., Liedl, K.R., Siems, K. and Jansen-Durr, P. (2013) Characterisation of nox4 inhibitors from edible plants. Planta Med. 79, 244-252
264. Vendrov, A.E., Madamanchi, N.R., Niu, X.L., Molnar, K.C., Runge, M., Szyndralewiez, C., Page, P. and Runge, M.S. (2010) NADPH oxidases regulate cd44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis. J. Biol. Chem. 285, 26545-26557
265. Green, D.E., Murphy, T.C., Kang, B.Y., Kleinhenz, J.M., Szyndralewiez, C., Page, P., Sutliff, R.L. and Hart, C.M. (2012) The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am. J. Respir. Cell Mol. Biol. 47, 718-726
266. Altenhofer, S., Radermacher, K.A., Kleikers, P.W., Wingler, K. and Schmidt, H.H. (2014) Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid. Redox Signal. 23, 406-427
267. Rey, F.E., Cifuentes, M.E., Kiarash, A., Quinn, M.T. and Pagano, P.J. (2001) Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ. Res. 89, 408-414
268. Ranayhossaini, D.J., Rodriguez, A.I., Sahoo, S., Chen, B.B., Mallampalli, R.K., Kelley, E.E., Csanyi, G., Gladwin, M.T., Romero, G. and Pagano, P.J. (2013) Selective recapitulation of conserved and nonconserved regions of putative NOXA1 protein activation domain confers isoform-specific inhibition of Nox1 oxidase and attenuation of endothelial cell migration. J. Biol. Chem. 288, 36437-36450
269. Csanyi, G., Cifuentes-Pagano, E., Al Ghouleh, I., Ranayhossaini, D.J., Egana, L., Lopes, L.R., Jackson, H.M., Kelley, E.E. and Pagano, P.J. (2011) Nox2 b-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radic. Biol. Med. 51, 1116-1125
270. Csanyi, G. and Pagano, P.J. (2013) Strategies aimed at Nox4 oxidase inhibition employing peptides from Nox4 b-loop and C-terminus and p22 (Phox) N-terminus: an elusive target. Int. J. Hypertens. 2013, 842827
271. Agrawal, U., Sharma, R., Gupta, M. and Vyas, S.P. (2014) Is nanotechnology a boon for oral drug delivery? Drug Discov. Today 19, 1530-1546